Recombinant multi-species MFF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MFF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This is a nuclear gene encoding a protein that functions in mitochondrial and peroxisomal fission. The encoded protein recruits dynamin-1-like protein (DNM1L) to mitochondria. There are multiple pseudogenes for this gene on chromosomes 1, 5, and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
The Alternative Names of target: MFF,Mitochondrial fission factor,EMPF2,GL004,C2orf33

Target products collectionGo to MFF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1171-Ab-1/ GM-Tg-hg-IP1171-Ab-2 Human MFF protein Human
GM-Tg-rg-IP1171-Ab-1/ GM-Tg-rg-IP1171-Ab-2 Rat MFF protein Rat
GM-Tg-mg-IP1171-Ab-1/ GM-Tg-mg-IP1171-Ab-2 Mouse MFF protein Mouse
GM-Tg-cynog-IP1171-Ab-1/ GM-Tg-cynog-IP1171-Ab-2 Cynomolgus/Rhesus macaque MFF monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1171-Ab-1/ GM-Tg-felg-IP1171-Ab-2 Feline MFF protein Feline
GM-Tg-cang-IP1171-Ab-1/ GM-Tg-cang-IP1171-Ab-2 Canine MFF protein Canine
GM-Tg-bovg-IP1171-Ab-1/ GM-Tg-bovg-IP1171-Ab-2 Bovine MFF protein Bovine
GM-Tg-equg-IP1171-Ab-1/ GM-Tg-equg-IP1171-Ab-2 Equine MFF protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1171-Ab-1/ GM-Tg-hg-IP1171-Ab-2; GM-Tg-rg-IP1171-Ab-1/ GM-Tg-rg-IP1171-Ab-2;
GM-Tg-mg-IP1171-Ab-1/ GM-Tg-mg-IP1171-Ab-2; GM-Tg-cynog-IP1171-Ab-1/ GM-Tg-cynog-IP1171-Ab-2;
GM-Tg-felg-IP1171-Ab-1/ GM-Tg-felg-IP1171-Ab-2; GM-Tg-cang-IP1171-Ab-1/ GM-Tg-cang-IP1171-Ab-2;
GM-Tg-bovg-IP1171-Ab-1/ GM-Tg-bovg-IP1171-Ab-2; GM-Tg-equg-IP1171-Ab-1/ GM-Tg-equg-IP1171-Ab-2
Products Name MFF protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MFF
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MFF protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.